Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. infect. dis ; 24(1): 81-84, Feb. 2020. graf
Artigo em Inglês | LILACS | ID: biblio-1089333

RESUMO

ABSTRACT China's compulsory annual livestock anthrax vaccination policy has remarkably reduced but not completely eradicated human anthrax infections. Herein we describe a sporadic human cutaneous anthrax outbreak involving two cases in 2018 in Shaanxi Province, both involving herdsman who dealt with unvaccinated and potentially sick cattle. Both patients showed Bacillus anthracis-positive blister smear and blood culture. Treatment with penicillin was followed by uneventful recovery for both. The prompt performance of the prophylactic measures successfully interrupted the further transmission of this sporadic human cutaneous anthrax outbreak.


Assuntos
Humanos , Masculino , Adulto , Dermatopatias Bacterianas/patologia , Antraz/patologia , Penicilinas/uso terapêutico , Bacillus anthracis/isolamento & purificação , China/epidemiologia , Surtos de Doenças , Resultado do Tratamento , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/epidemiologia , Antraz/tratamento farmacológico , Antraz/epidemiologia , Antibacterianos/uso terapêutico
2.
Braz. j. infect. dis ; 18(1): 110-113, Jan-Feb/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-703056

RESUMO

Pegylated interferon alpha (Peg IFN-α) in combination with ribavirin is the backbone of treatment in chronic hepatitis C (CHC). Cardiotoxicity due to interferon therapy is rare. The most frequent cardiovascular complications are arrhythmias and ischemic manifestations. Cardiomyopathy is extremely rare but can be life threatening. We present the case of a 41-year-old female patient with CHC in whom Peg IFN-α induced dilated cardiomyopathy and hypothyroidism. Chest radiography showed an enlarged and globular cardiac silhouette and pulmonary congestion. Echocardiography showed decreased left ventricular systolic function with an ejection fraction of 32% and fractional shortening of 15%. Cardiomyopathy had a complete remission after cessation of antiviral therapy with short-term heart failure medications and supportive care. Then we review the current literature about interferon induced cardiomyopathy in patients with HCV infection, as well as share our clinical experience in diagnosing and managing this rare complication.


Assuntos
Adulto , Feminino , Humanos , Antivirais/efeitos adversos , Cardiomiopatia Dilatada/induzido quimicamente , Hipotireoidismo/induzido quimicamente , Interferon-alfa/efeitos adversos , Ribavirina/efeitos adversos , Antivirais/administração & dosagem , Quimioterapia Combinada/efeitos adversos , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/administração & dosagem , Ribavirina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA